It was also recently shown that the disruption of the TET2 gene by lentiviral vector-mediated insertion of the chimeric antigen receptor (CAR) transgene led to the expansion of single CAR T cell in a patient with chronic lymphocyte leukemia and enhanced therapeutic efficacy36. This evidence concerns the gene TET2 and B-cell chronic lymphocytic leukemia.